Genetic markers predictive of response to induction chemoradiotherapy for locally advanced rectal cancers.

The Journal of the Kentucky Medical Association

Volumn 105, Issue 1, 2007, Pages 18-22

  Kudrimoti, Mahesh ^a   Lee, Eun Young ^a   Kang, Yuna ^a   Ahmed, Mansoor ^a   Mohiuddin, Mohammed ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; FEMALE; GENETIC MARKER; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33847777021     PISSN: 00230294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)